FLGT — Fulgent Genetics Balance Sheet
0.000.00%
Last trade - 00:00
- $608.78m
- $187.30m
- $289.21m
- 84
- 35
- 72
- 68
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 28.3 | 299 | 450 | 526 | 424 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 7.2 | 204 | 143 | 75.1 | 57.4 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 37.1 | 524 | 612 | 628 | 508 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 8.61 | 41 | 71.2 | 98.9 | 95.6 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 88.8 | 700 | 1,279 | 1,386 | 1,235 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 3.72 | 130 | 105 | 88.1 | 73 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 5.98 | 131 | 120 | 119 | 99.2 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 82.8 | 569 | 1,159 | 1,267 | 1,136 |
Total Liabilities & Shareholders' Equity | 88.8 | 700 | 1,279 | 1,386 | 1,235 |
Total Common Shares Outstanding |